From 2013 to 2023, the use of anxiolytic medicine in South Korea experienced fluctuations, initially declining from 14.9 units in 2013 to a low of 11.8 units in 2017, before gradually rising to 15.5 units in 2023. The year-on-year variations demonstrate significant shifts, with noticeable decreases in 2014 and 2016 and a strong resurgence starting in 2020. The CAGR over the last five years from 2019 to 2023 is 5.08%, indicating a steady, upward trend in anxiolytic use.
Looking ahead, the forecasted data suggests a continued moderate increase in anxiolytic medicine use, reaching 16.8 units by 2028 with an anticipated 5-year CAGR of 1.11%. Key future trends to watch include the impact of any potential healthcare reforms, changes in mental health awareness, and the influence of emerging non-pharmacological treatments.
